Literature DB >> 13585285

The status of phenylbutazone (butazolidin) in the treatment of rheumatic disorders.

W GRAHAM.   

Abstract

Entities:  

Keywords:  PHENYLBUTAZONE/therapeutic use; RHEUMATISM/therapy

Mesh:

Substances:

Year:  1958        PMID: 13585285      PMCID: PMC1830195     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Use of phenylbutazone in musculoskeletal disorders.

Authors:  H M ROBINS; L M LOCKIE; B NORCROSS; D J RIORDAN
Journal:  Am Pract Dig Treat       Date:  1957-11

2.  Some observations on 520 gouty patients.

Authors:  W C KUZELL; R W SCHAFFARZICK; W E NAUGLER; P KOETS; E A MANKLE; B BROWN; B CHAMPLIN
Journal:  J Chronic Dis       Date:  1955-12

3.  Phyenylbutazone (butazolidin).

Authors:  E C TOONE
Journal:  Bull Rheum Dis       Date:  1955-02

4.  Phenylbutazone therapy of arthritis and other painful musculoskeletal disorders.

Authors:  O STEINBROCKER; S BERKOWITZ; M EHRLICH; M ELKIND; S CARP
Journal:  J Am Med Assoc       Date:  1952-11-15

5.  Toxic effects of phenylbutazone.

Authors:  G D KERSLEY; L MANDEL
Journal:  Lancet       Date:  1953-05-23       Impact factor: 79.321

6.  The toxic effects of phenylbutazone (butazolidin); review of the literature and report of the twenty-third death following its use.

Authors:  E F MAUER
Journal:  N Engl J Med       Date:  1955-09-08       Impact factor: 91.245

7.  An evaluation of phenylbutazone (butazolidin) in the treatment of gout, rheumatoid spondylitis, rheumatoid arthritis and other conditions of the musculoskeletal system.

Authors:  E C TOONE; R IRBY
Journal:  South Med J       Date:  1957-05       Impact factor: 0.954

  7 in total
  2 in total

1.  Phenylbutazone and its derivatives with special reference to G.27202.

Authors:  F D HART; D BURLEY
Journal:  Br Med J       Date:  1959-04-25

2.  Feprazone, a new anti-inflammatory agent. Studies of potency and gastrointestinal tolerance.

Authors:  M R Fletcher; W Loebl; J T Scott
Journal:  Ann Rheum Dis       Date:  1975-04       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.